- Trump talks too much about about raising taxes.
- He changes his mind on things.
- He's probably going to be the next President.
- This will be not only a vast improvement but will also probably be a very good thing.
It’s why we’ll never have a Flat Tax. The super wealthy aren’t going to give up bullshit loopholes like carried interest.
“we only know here that what he’s saying is wrong.”
REALLY? Oh, wise one....tell us more for we are only ignorant serfs of our government and need your guidance.
The Ministry Of Propaganda is in a full court press to try to take Trump’s numbers down.
The Cheap Labor Express is very worried........
All I need to know about hedge fund people is that bastard who bought the drug company driving costs per pill from $7.50 to $750 overnight. People like him are equivalent to corporate raiders and crony capitalists. Produce nothing but profits for themselves. Totally agree with Trump.
LOL!
Wow, good morning it's a lovely new day! Yesterday stocks tanked over a % in heavier trade but that may be a good kind of basing/profit taking --witness today's stellar futures view for stocks today at +0.53% Metals ain't too shabby neither seen this AM at +0.73% and gold/silver are now at $1,126.30/$14.86. Econ reports today are just MBA Mortgage Index and Crude Inventories. Elsewhere:
- China factory slump casts pall but Europe pierces gloom Reuters - 7:50am LONDON Global shares fell on Wednesday after figures showing the biggest contraction in China's manufacturing sector since the global financial crisis intensified fears that a slowdown in the world's second-largest economy will spread more widely.
- Oil nears $50 as U.S. stock-draw balances China data
- Now We Know What Putin Is Up To In SyriaU.S. officials have begun to reveal the kinds of military equipment Russia has been moving into Syria, leaving little doubt that they are establishing an air base in the war-ravaged country. SLIDESHOW: ...The Fiscal Times
- As Investor Confidence In U.S. Falls, What It Means - John Shmuel, NP
- How Fed Inaction Changes the 2016 Election - Zachary Karabell, Politico
Ah, happy first day of Autumn too.
10% of the 50 stories on the FR page where this thread was found at the top were about Trump.
That % has been fairly consistent since he announced.
He’s dominating FR.
Trump knows more about hedge funds than this chump does.
Trump is a good communicator, and he’s telling average voters that in balance with reducing corporate taxes to help the economy, he’ll trim some ways that the wealthy get special treatment.
And sure, VC especially is good for the economy, but that doesn’t mean VC bonuses have to be tax advantaged. Maybe if anything he gives reason to reconsider how stock options are taxed once exercised.
- there really is an Occupy Wall Street wing of FR, and this is it, or
- these are people who if Donald Trump said that alligators give milk, they'd be lining up with bottles.
We had a deal with the Uber-Rich: We would PROTECT them from high taxes and they would PROTECT our country, by keeping it safe from invasion.
THEY HAVE WELCHED on their side by supporting Open Borders.
As far as I’m concerned a 99% tax rate on earning over $10M per year would be JUST FINE by me - at least until they start helping up clear out the country from illegals and building the wall. If they won’t hold up their side of the bargain, we conservatives DON’T OWE THEM JACK.
I’ve worked with these hedge fund guys and PE guys most of my career. Not a fan. The Fed pumping is making them billionaires. I am for getting some tax dollars back. In a perfect world I would say no way, however, the system is busted.
Your living in Panama and consider yourself an ex-patriot, so who gives a rat ass what you think, coward.
My understanding is the cap gains tax rate is to serve as a reward/inducement for putting your actual capital, either owned or borrowed, at risk in a business, a factory - any sort of venture where you gamble on the venture being successful. If it fails you lose your capital, go bankrupt, shoot yourself or whatever.
This sort of risk-it-all scenario doesn’t apply to the typical ‘hedge fund manager’ who is at best a consultant firm that is paid handsomely for applying tax expertise as it applies to investment strategies or advising/implementing a host of investment and leveraging techniques, etc.
Simply put, they basically are playing with other people’s money instead of their own. You invest your money in the hedge fund, they manage it. It’s why they are called a MANAGER.
Regardless of what he doesn't know about them, I suspect he still knows far more than Kevin D. Williamson does.
Capital gains should NOT be taxed. EVER! Period!
I’m sick of class warfare BS.
A biotech company founded by a former hedge fund manager recently purchased the rights to a critical antiparasitic drug and jacked up the price by more than 5,000%.
Startup Turing Pharmaceuticals acquired Daraprim, a drug used to treat toxoplasmosis, in August. Toxoplasmosis is a disease caused by a common parasite that can be deadly, especially for those who are immunosuppressed.
Turing immediately increased the price of Daraprim from $13.50 per pill to $750 per pill, The New York Times reported.
In an interview Monday with Bloomberg TV’s Betty Liu, the company’s CEO, Martin Shkreli, defended the move, explaining that they “need to turn a profit on the drug.”
Daraprim, which has been around for 62 years, has had multiple owners. Shkreli said that other companies were “giving it away almost.” He added that even at $750 per tablet, it’s “still underpriced relative to its peers.”
It costs little to make Daraprim, but Shkreli said there are other costs such as distribution costs that have increased over the years.
He said that they plan to use the money they make from Daraprim for alternative research to make “a better version” of the drug.
In the meantime, he said if someone can’t afford the drug, they will “give it away totally for free.”
Shkreli, 31, previously served as CEO of publicly-traded biotech company Retrophin. Last year, the board fired him because of stock irregularities, Bloomberg reported. Retrophin recently filed a lawsuit seeking $65 million in damages, alleging that he used the company to pay off claims of investors from his hedge fund. Shkreli told Forbes the company’s claims are “preposterous.”
http://www.businessinsider.com/turing-increases-price-of-darapim-2015-9